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ESTIMATING PERCENTILE-SPECIFIC CAUSAL EFFECTS: A CASE STUDY
OF MICRONUTRIENT SUPPLEMENTATION, BIRTH WEIGHT, AND INFANT
MORTALITY
December 16, 2004
Francesca Dominici, Scott L. Zeger, Giovanni Parmigiani, Joanne Katz, and Parul Christian
Abstract
In developing countries, higher infant mortality is partially caused by poor maternal and fetal nutrition. Clinical trials of micronutrient supplementation are aimed at reducing the risk of
infant mortality by increasing birth weight. Because infant mortality is greatest among the low
birth weight infants (LBW) (≤ 2500 grams), an effective intervention may need to increase the
birth weight among the smallest babies. Although it has been demonstrated that supplementation
increases the birth weight in a trial conducted in Nepal, there is inconclusive evidence that the
supplementation improves their survival. It has been hypothesized that a potential benefit of the
treatment on survival among the LBW is partly compensated by a null or even harmful effects
among the largest infants. Thus, two key scientific questions are whether the effect of the treatment on survival differs across the birth weight distribution (e.g. is largest among the LBW), and
whether the effect of the treatment on survival is mediated wholly or in part by increases in birth
weight.
Motivated by a community trial in Nepal, this paper defines population and causal parameters
for estimating the treatment effects on birth weight and on survival as functions of the percentiles
of the birth weight distribution. We develop a model with potential outcomes and implement
principal stratification for estimating and comparing the causal effects of the treatment on mortality
in sub-populations of babies defined by their birth weights. We use a Bayesian approach with data
augmentation to approximate the posterior distributions of the parameters taking into account
uncertainty associated with the imputation of the counterfactuals. This approach is particularly
suitable for exploring the sensitivity of the results to modelling assumptions and other prior beliefs.
Our analysis shows that the average causal effect of the treatment on birth weight is equal to
68 grams (95% posterior regions 25 to 110) and that this causal effect is largest among the LBW.
Posterior inferences about average causal effects of the treatment on birth weight are robust to
modelling assumptions. However inferences about causal effects for babies at the tails of the birth
weight distribution can be highly sensitive to the unverifiable assumption about the correlation
between the observed and the counterfactuals birth weights. Among the LBW infants who have a
large causal effect of the treatment on birth weight, we found that a baby receiving the treatment
has 5% to 7% less chance of death if the same baby had received the control. Among the LBW,
we found weak evidence supporting an additional beneficial effect of the treatment on mortality
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independent of birth weight.
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1

Introduction

The reduction of infant mortality remains a major public health goal (Child Health Reserach
Project, 1996), particularly in developing countries where current rates are an order of magnitude
higher than in Europe, North America, and Japan. In developing countries, higher infant mortality
is partially caused by poor maternal and fetal nutrition as reflected in the distribution of infant birth
weights. One intervention trial have attempted to reduce infant mortality by improving maternal
micronutrient sufficiency (Christian et al., 2003a). The idea is to improve maternal nutritional
status thereby improving fetal growth and reducing the risk of infant mortality. Because infant
mortality is greatest among low birth weight (LBW ≤ 2500 grams) and very low birth weight
(VLBW ≤ 1500 grams) infants, it is assumed that an effective intervention must increase birth
weight among the smallest babies, that is, in the left tail of the birth weight distribution. That
maternal nutritional supplementation increases birth weight has been demonstrated in replicated
randomized trials in several countries (Lechtig et al., 1975; Ceesay et al., 1997; Caulfield et al.,
1999; Christian et al., 2003a). However, to date, there is limited direct evidence that maternal
supplementation causes a reduction in the prevalence of babies born at the smallest weights and
that this reduction improves their survival (Garner et al., 1992; McIntire et al., 2001; West et al.,
1999; Katz et al., 2000a; Rasmussen, 2001; Christian et al., 2003b).
The methods in this paper are motivated by a double blind randomized community trial in
rural Nepal (Christian et al., 2003a). The intervention program provided weekly iron, folic acid
and vitamin A while the control was weekly vitamin A alone. The 1051 and 947 pregnant women
that were assigned to the control and treatment delivered 866 and 766 live born infants, respectively.
Details on the study designs including the rational for the selection and exclusion of the women
in the study are detailed in Christian et al. (2003a). The team measured the birth weight within
72 hours of delivery and then followed the infants for one year to determine whether or not they
survived. In the motivating study, treatments were randomized to 426 communities rather than
to individual women. This can create some correlation among the birth weights and infant deaths
within communities. It is a minor extension of the methods discussed in this paper to account for
this clustering which turns out to be of negligible magnitude for the infant mortality outcome. To
simplify the notation and exposition, we will not address clustering here.
The interesting aspect of this study is that the investigators anticipate that antenatal ironfolic acid supplementation may affect birth weight and ultimately survival differently among the
smaller and larger babies. That is, they hypothesize that there could be an interaction between
the treatment effect and the birth weight percentiles. Cox (1984) referred to this situation as the
most basic form of interaction. Doksum and Sievers (1976) defines a similar form of interaction by
allowing the treatment effect to vary as a function of the health response. Koenker and Bassett
(1978) introduced quantile regression methods which model the quantile function of an outcome
3
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variable as a function of covariates, and applied this approach to survival times where the regression
parameters are allowed to depend on the quantile of interest (Koenker and Geling, 2001). Dominici
et al. (2003) recently introduced Smooth Quantile Ratio Estimation (SQUARE), a novel method
for estimating the difference in medical expenditures between persons with and without a disease
as a function of the medical expenditures percentiles.
The second interesting question from this study is whether the antenatal iron-folic acid supplementation improves survival largely through its positive effect on birth weight. The hypothesis
is that supplementation will improve intra-uterine growth, lowering the risk of LBW and thus increasing the chance of survival during the first year after a live birth. Therefore we are interested in
investigating the relative importance of different pathways for the antenatal iron-folic acid supplementation on survival. By one pathway, the intervention affects survival only throughout a change
in birth weight (the so called “mediated effect”). A second possible pathway is that intervention
affects survival over and above its effect on intra-uterine growth, that is through other mechanisms
that do not involve birth weight. We refer to this pathway as a “direct effect”.
To explore the association between birth weight and mortality, we fit a logistic regression model
expressing the log odds of infant death as a separate smooth function of the birth weight for the
control and intervention groups. The top panel of Figure 1 shows the smoothed histograms of the
birth weights. The bottom panel shows the estimated smooth curves with 95% confidence bands
plotted in correspondence to the ranges of the measured birth weights in the two groups. These
exploratory plots suggest that: 1) the probability of death decreases as the birth weight increases
and tends to rise again for the heaviest babies in the control group; 2) approximately 43% and
34% of the babies in the control and in the intervention groups are LBW, respectively, suggesting
that the treatment may reduce the percentage of LBW; and 3) the visual inspection of the two
smoothed histograms suggests that the treatment increases birth weight for the smaller babies only,
thus indicating that the treatment effect on birth weight might vary with respect to the percentiles
of the birth weight distribution.
The statistical literature on surrogate endpoints and causal inference extensively discusses posttreatment variables in clinical trials and observational studies. Prentice (1986) first proposed criteria for a perfect surrogate (e.g. the birth weight), the most important being that the final response
is conditionally independent of treatment given the surrogate. When the assumption of conditional independence is violated, related approaches have been proposed that compare results of
the regression of the health response on the treatment with and without the adjustment for the
intermediate variable (Freedman et al., 1992; Daniels and Hughes, 1997; Buyse and Molenberghs,
1998; Begg and Leung, 2000; Leung, 2001; Molenberghs et al., 2001; Xu and Zeger, 2001; Cowles,
2002). Robins (1989), Robins and Greenland (1992), and Pearl (2000) have developed identifiability results for direct and indirect causal effects under the framework of potential outcomes and
they define an “individual direct effect” as the counterfactual effect of a treatment on an outcome
4
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when the intermediate variable is set at the value it would have had if the individual had not
been treated (see also Cole and Hernan (2002)). These identifiability results have been recently
generalized by van der Laan and Petersen (2004). Frangakis and Rubin (2002) proposed a novel
approach for defining causal effects adjusted for post-treatment variables. This approach, known as
“principal stratification”, is based upon a comparison of treatment effects on the outcome among
sub-populations for whom a causal effect of treatment on the post-treatment variable did and did
not occur.
The broad objectives of this paper are to develop and apply a statistical model with counterfactual variables for this birth weight-mortality study. The contributions of this paper are to: 1)
define and compare population and causal parameters (Holland, 1986) that measure the effects of
an intervention on a clinical outcome (infant mortality) that are allowed to vary with the percentiles
of the post-treatment variable (birth weight); 2) extend and apply a causal statistical framework
to compare the causal “direct” effect of the treatment on mortality, from the causal effect of the
treatment on mortality that is “mediated” by post-treatment changes in birth weight; 3) develop
a Bayesian approach with data augmentation (Tanner and Wong, 1987; Tanner, 1991; Albert and
Chib, 1993; Chib and Greenberg, 1998) for approximating the marginal posterior distributions of all
parameters of interest accounting for the uncertainty about the missing counterfactuals; 4) quantify
the sensitivity of causal inferences to key assumptions for which there are not direct observations
in the data set.
In Section 2, we introduce notation, specify our model, and define the population and causal
parameters. In section 3, we define the complete likelihood function for the observed data and
the missing counterfactual data. In this section, we also describe our Monte Carlo Markov Chain
with data-augmentation algorithm (Tanner and Wong, 1987; Tanner, 1991) for approximating the
posterior distributions of all the unknown parameters and the unobservable variables. In Section
4, we summarize the results by comparing causal and population parameter estimates. We explore
sensitivity of the causal parameter estimates to the unverifiable assumptions about counterfactuals,
to model specification, and to distributional assumptions. In Section 5, we discuss future research
opportunities.

2

Definition of Population and Causal Parameters

In this section, we define population and causal parameters of scientific interest in terms of counterfactual variables. To establish notation, let Zi be the treatment indicator for live birth i that
takes values 0 or 1 to indicate the control and the treatment groups, respectively. Let W iobs be
the observed birth weight measurement within the 72 hours of the delivery, and let Y iobs be the
observed mortality indicator within one year. Let n0 = 866 and n1 = 766 be the number of live
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births for the control and the treatment groups respectively and let N = n 0 + n1 = 1632 be the
total number of live births.
Adopting a causal model with potential outcomes (Rubin, 1978; Holland, 1986), let Z be the
N -dimensional vector of treatment assignments with ith element Zi , and Wi (Z) be the birth weight
of baby i given the randomly allocated vector Z. We define Yi (Z, W ) to be the binary random
variable for the mortality indicator for baby i corresponding to the vector of birth weights W and
the vector of treatment assignments Z. We refer to Yi (W , Z) and Wi (Z) as potential outcomes.
To assure a valid causal interpretation of the causal estimands defined below, we make the following
usual assumptions:
1. Stable Unit Treatment Value Assumption (SUTVA) (Rubin, 1978): the potential outcomes
of each baby i are unrelated to the treatment status of other babies. That is, the birth
weight and the mortality potential outcomes of each baby are not affected by the treatment
assignment of others. Therefore we can write Yi (Z, W ) and Wi (Z) as Yi (Zi , Wi ) and Wi (Zi ),
respectively;
2. Ignorable Assignment: assignment to the supplementation is at random;
3. Perfect compliance with the treatment: all mothers take the assigned dose in both treatment
groups.
Note that Yi (0) and Wi (0) are defined for all N babies, but only observed for the n0 babies in
the control group of the study. Similarly, Yi (1) and Wi (1) are defined for all N babies, but only
observed for the n1 babies in the intervention group. Thus we denote the observed and the missing
data as Yiobs = {Yi (z), if z = Zi } and Yimis = {Yi (z), if z 6= Zi }, respectively. Similar definitions
apply for Wiobs and Wimis .
The parameters of interest are defined in Tables 1 and 2 for birth weight and mortality respectively. The first two rows of Table 1 indicate population parameters measuring difference between
the means (∆W ) and the percentiles (∆W
p ) of the population of birth weights for the two treatments. Note that the parameter ∆W
p is defined as Q1 (p) − Q0 (p) where Q1 (p) and Q0 (p) are the
quantile functions of the marginal distributions of Wi (1) and Wi0 (0) respectively.
The last two rows of Table 1 define the causal parameters measuring the effects of the treatment
on birth weight, on average (τ W ), and specific to the percentiles of the birth weight distribution
W
(τpW ). Note that ∆W
p is a population parameter, whereas τp is a causal parameter: in the definition
of ∆W
p , we consider the difference in percentiles of two different distributions of birth weights. In
the definition of τpW , we consider the expected difference in birth weights Wi (1)−Wi (0) for the same
baby (Holland, 1986) whose control value Wi (0) is at the p-percentile of the control distribution.
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Table 2 summarizes the population and causal parameters for the treatment effect on infant
mortality. Prior to defining these parameters, we need to specify a functional relationship between
death and birth weight. Substantive knowledge and our exploratory analyses indicates that the
following logistic regression model is a reasonable approximation to the actual mortality process:
logitP r{Yi (Zi ) = 1 | Zi , Wi (Zi )} = β0 + β1 Zi + s(Wi (Zi ), 3), Zi = 0, 1.

(1)

where s() denotes a natural cubic splines with 3 knots.
By specifying this parametric model we make two key assumptions.
4. Conditional independence of survival from the counterfactual birth weight given the treatment
assignment and the observed birth weight: For each baby, we assume that the probability of
death under the treatment depends only on the birth weight under that treatment, and it does
not depend on what birth weight would have been had the same baby been randomized to
the other group. That is we assume, P r{Yi (Zi ) = 1 | Zi , Wi (Zi ), Wi (1 − Zi )} = P r{Yi (Zi ) =
1 | Zi , Wi (Zi )};
5. No interaction between the direct treatment effect on survival and the birth weight: We assume
that the direct effect of the treatment on mortality is the same for all babies and does not
vary with respect to the birth weight distribution. That is we can write:
logitP r{Yi (1) = 1 | Zi = 1, Wi (1) = w} − logitP r{Yi (0) = 1 | Zi = 0, Wi (0) = w} = β1 .
This assumption can be relaxed by assuming a linear or non-linear interaction between the
treatment and the birth weight, for example by replacing β1 Zi with β1 (Zi × Wi (Zi )) – or
more generally with Zi × s2 (Wi (Zi ), 3) – in model (1).
The first two rows of Table 2 indicate population parameters measuring treatment effect on
mortality, on average (∆Y ), and conditional on a specific percentile of the birth weight distribution
(∆Yp ). Note that ∆Yp defines the difference in the probability of death between treated and non
treated infants who are at the same percentiles of their respective birth weight distribution. Thus
∆Yp is not a causal parameter, because these differences correspond to two different sub-populations
of babies.
The last two rows of Table 2 indicate the causal parameters measuring the effects of treatment
on infant mortality, on average (τ Y ), and specific to the percentiles of the birth weight distribution
(τpY ). Thus, for a specific p, τpY can be interpreted as a causal effect which compares the probability
of death for the same baby i given that the assumption that his/her birth weight under the control
(Wi (0)) is at the p-th percentile.
In the last row of Table 2, we use the idea of principal stratification by Frangakis and Rubin (2002) for defining causal parameters of the effects of treatment on infant mortality that are
7
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“adjusted” and “mediated” by post-treatment changes in birth weight. More specifically, τ 1Y and
τ2Y are the effects of treatment on mortality in the two sub-populations of LBW babies for whom
the treatment effect on birth weight was smaller and larger than 50 grams, respectively. Thus
a comparison between τ1Y and τ2Y measures the degree to which a causal effect of treatment on
mortality occurs together with a causal effect of treatment on the birth weight among the LBW.
The parameters τ3Y and τ4Y are the analogues of τ1Y and τ2Y for the not-LBW infants, that is for
the infants with birth weight larger than 2500 grams.
All causal parameters (τ ) depend upon unverifiable assumptions about the joint distribution
of the counterfactual pairs of variables {Wi (0) and Wi (1)}, and {Yi (0) and Yi (1)}. In order to
estimate the average causal effects (τ s), we make the following key but unverifiable assumptions
about the correlation between the observed outcomes and their counterfactuals:
6. Correlation between the observed and the counterfactual birth weight: we assume that the
correlation between Wi (Zi ) and Wi (1 − Zi ), denoted by ρ, varies between 0.5 and 0.9.
7. Odds ratio between the observed and counterfactual mortality given birth weight: Let µ i (11)
be the joint probability that the same baby i would die in both groups defined as P (Y i (Zi ) =
1, Yi (1 − Zi ) = 1 | Wi (Zi ), Wi (1 − Zi )). We assume that the odds ratio ψ = (µ(11) × µ(00))/
(µ(10) × µ(01)) varies between 3 and 20.
These choices are arbitrary but based on prior knowledge. As a guide for reasonable choices
of ρ, we have used data from this randomized trial and from other data sources (Rahmathullah
et al., 2003; Katz et al., 2000b, 2001) to estimate the correlations of birth weights for two successive
children born to the same mother and birth weights for twins. We found that these correlations
range from 0.45 to 0.7. The analogous odds ratios for mortality were estimated to be 1.8 and 52
respectively. As detailed in the next section, we will study the dependence of our causal inferences
to the prior choices on the correlation coefficient ρ and on the odds-ratio ψ.

3

A Bayesian Implementation of Causal Inference

In this section, we define a Bayesian approach for approximating the marginal posterior distributions
of the population and the causal parameters defined in Section 2. We start by defining the likelihood
function for the complete data as:

L(η 1 , η 2 ) =

N
Y

P r(Yi (1), Yi (0) | Wi (1), Wi (0), η 1 ) × f (Wi (1), Wi (0) | η 2 ).

(2)

i=1

8
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In section 3.1, we specify f (Wi (1), Wi (0) | η 2 ) as a mixture of normal distributions. In Section 3.2, we specify an odds-ratio association model for bivariate binary variables P (Y i (1), Yi (0) |
Wi (1), Wi (0), η 1 ) (Liang et al., 1992). This model will be consistent with equation (1). In section
3.3, we then detail the elicitation of the prior distributions and the implementation of the MCMC
methods with data augmentation to obtain posterior samples of all the unknown parameters and
the missing counterfactuals variables.

3.1

Statistical model for birth weight

We begin our specification of the joint distribution in Equation (2), by assuming that the marginal
distributions of the random variables Wi (z), z = 0, 1, i = 1, . . . , N are a mixture of J(= 3) normal
distributions:
QJ
2
(3)
fz (Wi (z) | µz , σ 2z , γ z ) =
j=1 γzj φ(Wi (z); µzj , σzj ), z = 0, 1
where φ(x; µ, σ 2 ) is the density of a normal distribution with mean µ and variance σ 2 , µz =
(µ1z , µ2z , µ3z ), σ z = (σ1z , σ2z , σ3z ), and γ z = (γ1z , γ2z , γ3z ), where γjz are the mixing probabilities
P
with Jj=1 γjz = 1. To identify the mixture we set the constraint µ1z < µ2z < µ3z (Kadane, 1974).
2 = σ 2 = 2 × σ 2 : assigning a larger variance to the outside components
We further assume that σ1z
3z
2z
of the mixture is designed to flexibly capture heavy-tailed distributions. For ease of notation, we
2 .
will set σz2 = σ2z
W
This distributional assumption allows the parameters ∆W
p and τp to vary flexibly as functions of
the percentiles (p) of the birth weight distribution. If instead of the mixture model (3), we assumed
−1
that Wi (z) ∼ N (µz , σz ), then ∆W
p = (µ1 −µ0 )+(σ1 −σ0 )Φ (p). Therefore, the simpler assumption
of normality for the marginal distributions of Wi (0) and Wi (1) imposes a specific parametric form
for ∆W
p which does not depend on p for σ1 = σ0 . In the results section, we will calculate the
posterior probability of σ02 6= σ12 to provide evidence in favor of the assumption that ∆W
p depends
W
on p, and we will explore the sensitivity of the posterior distribution of ∆p as a function of p,
under the mixture model and under the simpler assumption of normality with σ0 = σ1 .

To allow for a correlation between Wi (0) and Wi (1), we assume that the standardized variables
z (Wi (z))], z = 0, 1 have a bivariate normal distribution with mean zero, variance 1 and
correlation ρ, where Φ is the cdf of a standard normal distribution and Fz is the cdf of Wi (z).

Φ−1 [F

In this formulation for the joint distribution of (Wi (0), Wi (1)), letting ρ = 1 corresponds to the
rank preservation assumption used by Efron and Feldam (1991). Our specification allows for a single
interpretable parameter capturing the correlation between W i (0) and Wi (1), while allowing for a
flexible representation of the two marginal distributions. An alternate stochastic generalization of
the rank preservation assumption, obtained by specifying a probabilistic distribution on the ranks,
has also been developed by Dobbin and Louis (2003).
9
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3.2

Statistical model for infant mortality given birth weight

We specify the causal model for the joint distribution of the two outcome indicators conditional
on the birth weights. Following Liang et al. (1992), we parametrize the 2 × 2 joint distribution
[Yi (0), Yi (1) | Wi (0), Wi (1)] in terms of the margins and the odds ratio. Specifically, we assume
that:
P (Yi (0) = yi (0), Yi (1) = yi (1) | Wi (0), Wi (1), η 1 ) = µi (0)yi (0) (1 − µi (0))1−yi (0) ×
× µi (1)yi (1) (1 − µi (1))1−yi (1) +
(−1)yi (0)−yi (1) (µi (11) − µi (0)µi (1))

(4)

where µi (1) = P r(Yi (Zi ) = 1 | Zi , Wi (Zi )) is defined in Equation (1). The parameter µi (11) =
P r(Yi (0) = Yi (1) = 1 | Wi (0), Wi (1)) is a known function of the marginal probabilities µi (1), µi (0)
and of the odds ratio ψ.

3.3

Prior Distributions and Computation

Distributional assumptions in Sections 3.1 and 3.2 involve the following vectors of unknown parameters: 1) η 1 = (β, ψ) where β includes β0 , β1 and the spline coefficients defined in the regression
model (1); and 2) η 2 = (µ0 , µ1 , σ0 , σ1 , γ 0 , γ 1 , ρ) denoting all the unknown parameters of the mixture (3). As stated in assumptions 6 and 7, the parameters ρ and ψ measure the association between
the observed outcomes and their counterfactuals and they cannot be identified from the observed
data. We specify prior distributions on the parameter of the mixture that are proper but vague
enough to achieve goodness of fit to the observed birth weights. These choices are summarized in
Table 3. In the results section, we explore the sensitivity of our results with respect to different
values of ρ and ψ and we evaluate the goodness of fit of the empirical distributions of the observed
birth weights.
To investigate the posterior distributions of all parameter of interest we implement Monte Carlo
Markov Chain methods with data augmentation for imputing the missing data (Tanner, 1991; Gelman et al., 1995). Bayesian sampling of parameters of normal mixture distributions is typically
handled by introducing auxiliary variables representing mixture component indicators, which results in closed form full conditionals (Diebolt and Robert, 1994). In our case, this option was not
practical because of the special correlation structure we used, and because the unobserved birth
weight variables enter the logistic component of the likelihood as well. We thus implemented a
Metropolis-within-Gibbs (Tierney, 1994) approach, in which both the parameters and the counterfactual variables are sampled using a random walk proposal, truncated to the region defined by the
constraints wherever applicable.
For each posterior sample of the unknown parameters and counterfactuals, we obtain a posterior
sample of the p-specific parameters as follows. To obtain a posterior sample of ∆ W
p , we sort Wi (0)
10
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and Wi0 (1) within the two groups of treated and untreated babies separately and then we take their
difference. To calculate a posterior sample of τpW , we sort by Wi (0) and then we take the difference
between the sorted Wi (0) and its matched Wi (1) for the same infant i. To calculate a posterior
sample of ∆Yp , we first sort Yi (0) with respect to Wi (0) and Yi0 (1) with respect to Wi0 (1) within
each of the two groups separately, and then we take the difference. Finally to calculate a posterior
sample of τpY , we sort Yi (0) with respect to Wi (0), and then we take the difference between the
sorted Yi (0) and its matched Yi (1) for the same baby i. We smoothed the posterior samples of
these percentile-specific parameters to reduce monte carlo variability in the posterior probability
bounds.

4

Results

Figure 2 shows the posterior means and 95% posterior regions of the p-specific treatment differences
in birth weight (∆W
p ) comparing the treatment and control populations, plotted with respect to p
under the two modelling assumptions for (Wi (0), Wi (1)). In Panel (a) Wi (0), Wi (1) have a bivariate
normal distribution with equal variances. In Panel (b) Wi (0), Wi (1) have a mixture of normal
distributions with correlation ρ as defined in Section 2. The triangles denote the difference between
the empirical quantile functions for the observed data. The black dots denote the posterior means
of ∆W
p as a function of p.
Under the two modelling assumptions for the birth weights, the posterior means of ∆ W
p are
generally consistent with the observed differences. However these two sets of estimates are very
different at the smallest and at the largest percentiles. In fact in Panel (a), ∆ W
p is a constant function
of p as is reflected in the flat line relationship in the lower left panel. If we fit a bivariate normal
distribution without the constraint of equal variances, the posterior probability that log σ 12 − log σ02
is less than zero is 97%, thus providing strong evidence that ∆W
p varies with respect to p. Panel
(b) shows that, when a more flexible mixture model is used, the effect of the intervention on the
birth weight appears to vary by percentiles of the birth weight distribution. Therefore, estimating
the posterior means of ∆W
p by use of summaries of the posterior samples of W s without imposing
the normality assumption, provides a useful diagnostic tools for the performance of the algorithm
and indicates that our mixture model with unequal variance in preferred and it will be used to
report the results described below. Under the mixture model, we estimated a difference in birth
weights quantiles between groups equal to 100 grams (95% posterior interval: 30 to 190) for the
smallest babies (p ' 0.05) and that the treatment difference was close to zero for the largest babies
(p ' .95). This is an ideal improvement as it has its greatest effect where the need is greatest.
Figure 3, Panel (a), shows the posterior means and 95% posterior regions of the p-specific causal
effects of treatment on birth weight (τpW ) under the mixture model, ρ = 0.9 and ρ = 0.5 (darker
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line). The vertical line is placed at the 0.42 percentile corresponding to 2500 grams in the control
sample. Note that under the hypothesis of rank preservation (ρ = 1), then τ pW = ∆W
p . For ρ
different than one, population and causal parameter inferences differ by an amount that increases
towards the tails of the birth weight distribution. Among LBW infants, we found that the average
causal effects of the intervention on the birth weight are equal to 150 grams (95% posterior regions
100 to 300 grams) and to 410 grams (95% posterior regions 230 to 750 grams) for ρ = 0.9 and 0.5,
respectively.
Figure 3, Panel (b), shows the sensitivity of the posterior distributions of the causal effect of
treatment on birth weight (τpW ) separately for three sub-populations of babies (Wi (0) ≤ 1500, 1500 <
Wi (0) ≤ 2500, Wi (0) < 2500), and overall for all babies, with respect to (ρ, ψ). The horizontal dotted line is placed at the sample mean difference (∆W ). Within each sub-population, these causal
effects are very sensitive to ρ but not to ψ. However the average causal effect of supplementation
on birth weight (τ W ) – estimated to be 68 grams (95% posterior regions 25 to 110) – is robust to
modelling assumptions about both ρ and ψ.
Figure 4, Panel (a), shows the posterior means and 95% posterior regions of the p-specific
difference in infant mortality rates between the treatment and control populations (∆ Yp ) plotted
with respect to the percentiles of the birth weight distributions. For a specific p, ∆ Yp is the difference
in the probability of death between the babies with birth weights Wi (1), Wi0 (0), each at the ppercentile of their respective birth weight distributions. The vertical dotted line is placed at the
0.42 percentiles corresponding to 2500 grams in the control sample. There is no convincing evidence
of a difference in the probabilities of death across the entire birth weight distribution.
Figure 4, Panel (b), shows the posterior means and 95% posterior regions of the p-specific causal
effect of the treatment on infant mortality (τpY ) plotted with respect to the percentiles of Wi (0) for
ρ = 0.9 and ρ = 0.5. For a specific p, τpY is defined as the difference in the probability of death
for the same baby i whose control birth weight {Wi (0)} is at the p-th percentile. For ρ = 0.9, we
found that the causal effect of supplementation on mortality adjusted by birth weight is negative
(intervention better) for the smaller babies and that this effect diminished for the larger babies,
although with wide posterior regions. Posterior inferences on τpY are sensitive to ρ at the smallest
percentiles. For ρ = 0.5 (darker line), there is stronger support for a beneficial “direct” effect of
the supplementation on mortality among the very small babies only.
Figure 4, Panel (c), shows the posterior distributions of the causal effects of treatment on
mortality for different values of (ρ, ψ) among different sub-population of babies. More specifically
the posterior distributions are shown separately for four sub-populations of babies: 1) babies with a
birth weight smaller than 2500 grams (LBW infants) for whom there is a causal effect of treatment
on birth weight smaller than 50 grams (τ1Y ); 2) LBW infants for whom there is a causal effect of
treatment on birth weight larger than 50 grams (τ2Y ); 3) babies with a birth weight larger than 2500
12
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grams (not-LBW infants) for whom there is a causal effect of treatment on birth weight smaller
than 50 grams (τ3Y ); and 4) not-LBW infants for whom there is a causal effect of treatment on
birth weight larger than 50 grams (τ4Y ). The four boxplots at the far right show the posterior
distributions of the total (direct plus mediated) causal effect of supplementation on mortality on
average for all babies (τ Y ).
The four boxplots on the left (posterior distributions of τ1Y ) indicate that, among the LBW
babies with little change in birth weight after the supplementation, there is only weak evidence
that antenatal iron-folic acid supplementation affects survival. The second set of four boxplots
(posterior distributions of τ2Y ) suggest that, among the LBW babies with absolute changes in birth
weight after the supplementation larger than 50 grams, there is much stronger evidence that the
antenatal iron-folic acid supplementation affects survival. The posterior means of these “mediated”
causal effects for ρ = 0.9 and ρ = 0.5 are equal to -0.046 and -0.071 (95% posterior regions -0.11
to 0.02 and -0.13 to -0.02), respectively. These results indicate that a LBW infant receiving the
intervention has 5% to 7% smaller chance of death than if the same baby had received the control
intervention. This higher chance of death is due to changes in birth weight from the control to the
treatment larger than 50 grams. The posterior distributions of the parameters τ 3Y and τ4Y indicate
that there is little evidence of a beneficial effect of supplementation on infant mortality for the
not-LBW babies. The average causal effect of supplementation on mortality is robust to modelling
assumptions and to (ρ, ψ).
Finally, we evaluate the consistency of the model assumptions and prior distributions with the
(j)
patterns in the observed data. Figure 5 (top) shows 95% posterior regions of F z (Wi (z), θ z ), z =
0, 1 where Fz are the cumulative distribution functions (cdfs) from the mixture model defined in
(j)
Equation (3) and θ z are the j th posterior samples of the parameters of the mixture. The black
lines are the corresponding empirical cdfs, estimated directly from the observed birth weights. We
see that the assumed model is reasonably consistent with the data.

5

Discussion

A micronutrient supplementation trial is considered effective if the treatment reduces the risk of
infant mortality either directly or through increases in birth weight. Because infant mortality is
greatest among low birth weight infants (LBW), an effective intervention must increase birth weight
mainly among the smallest babies. In addition, it has been hypothesized that the supplementation
could be harmful if it increases birth weight among the largest babies. A community-based trial
in Nepal has shown that a multiple micronutrient supplementation increases birth weight but the
limitation in the study size have to date prevented us from establishing that this translates into a
mortality benefit (Christian et al., 2003b).
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In this paper we develop a causal model to evaluate the efficacy of micronutrient supplementation trials in developing countries. We focus on whether the supplementation increases birth
weight and ultimately survival differently among the smaller and the larger babies, and whether
the supplementation improves survival largely through its positive effect on birth weight (mediated
effect) or it improves survival even without affecting the birth weight (direct effect). Addressing
these scientific questions is challenging because birth weight is a post-treatment variable (i.e. intermediate variable) that is in the causal pathway between nutritional supplementation and infant
mortality.
Although average causal effects are robust to unverifiable assumptions about counterfactuals,
posterior inferences on causal effects toward the tails of the birth weight distribution (for example
among LBW infants) can be highly sensitive to ρ. More specifically we found that: among LBW
infants, the effect of micronutrient supplementation on birth weight is greatest and its estimates
size is highly sensitive of ρ: lower values of ρ correspond to a larger causal increase in birth weight.
The posterior distributions of the population and causal parameters are evaluated by using
Bayesian inferences with data-augmentation methods (Tanner and Wong, 1987; Tanner, 1991; Albert and Chib, 1993; Chib and Greenberg, 1998). A nice feature of this inferential approach is
that we can evaluate the posterior distributions of the quantities of interest taking into account
uncertainty in the imputation of the the missing counterfactuals. In addition, we can easily explore
the sensitivity of the posterior inferences to unverifiable assumptions about the correlation between
the observed and the counterfactual variables.
To implement our approach we make several important assumptions. The first two (SUTVA,
random assignment), are justified by the randomization of the treatment assignment and the independence of the sampling units. Third we assume perfect compliance. The compliance for this
trial was very good and did not depend on the treatment (Christian et al., 2003a). The fourth and
the fifth assumptions are in the logistic regression model for the probability of infant mortality as
a function of the treatment indicator and the birth weight for the treatment received. Under the
fourth assumption, we expect that that the risk of mortality under the treatment would depend only
on the actual birth weight and not on the birth weight for the intervention not received. The fifth
assumption, that the direct effect of the intervention on mortality is common to babies of all sizes,
is consistent with the patterns in Figure 1 but there is little statistical power to show otherwise.
Finally the sixth and the seventh assumptions are about the associations between the observed
and the missing counterfactuals and these associations cannot be estimated from the data. To deal
with this unidentified problem we: a) use data on siblings to estimate lower bounds for ρ and ψ
and use those as a guide for our prior choices and sensitivity analyses; b) explore the sensitivity
of estimated causal parameters with respect to choices for ρ and ψ; and c) compare inferences on
causal parameters versus inferences on population parameters which are not affected by ρ and ψ.
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The methodological development of this paper cuts across several contributions in quantile
regression and causal inference literature. For example, we could have estimated the p-specific
W
parameter ∆W
p by use of a quantile regression model of the form Q(p) = α p + ∆p Zi (Koenker
and Bassett, 1978) where Q(p) is the quantile function of Wiobs , and Zi represents the treatment
assignment. However in this paper we extend the traditional definition of p-specific regression
coefficients in two ways: 1) we introduce p-specific regression coefficients in presence of posttreatment variables where the treatment effect on the dependent variable is allowed to vary with
respect to the percentiles of an intermediate variable (∆Yp ); 2) we introduce causal analogues of pspecific regression coefficients which vary with respect to the percentile of the counterfactual W i (0)
(τpW , τpY ).
Estimation methods in quantile regression are based upon finding the solution of a quantile
regression minimization problem with a pre-specified loss function (Koenker and Bassett, 1978).
Bayesian analogues are described by Yu and Moyeed (2001). Our estimation approach for the pspecific parameters is simply based upon transformations of the posterior samples of (W i (0), Wi (1)).
By modelling the marginal distributions of Wi (0) and Wi (1) as a mixture of normals instead of a
single normal distribution, we allow very flexible shapes for the p-specific treatment effects. This
gain in goodness of fit, especially at the tails of the birth weight distribution is clearly shown in
Figure 2 and supported by the posterior inferences on the variances components of the mixture
model.
In the causal inference literature, Angrist et al. (1996) showed how instrumental variables (IV)
can be embedded within the Rubin Causal Model for estimating an average causal effect in the
presence of a binary post-treatment variable. These authors introduced five assumptions under
which an IV-estimator (Durbin, 1954) can be interpreted as the average causal effect. The first two
assumptions are the SUTVA and the random assignment. The third assumption, called exclusion
restriction, assumes that any effect of the treatment on the health outcome must be via an effect
of the treatment on the post-treatment variable, that is, there is no direct effect. We are not
making this assumption: we use principal stratification to compare the different causal pathways
on how the supplementation affects survival. In addition Angrist et al. (1996) assume monotonicity
in the post-treatment variable, that is that Wi (1) ≥ Wi (0), we instead define a joint model for
(Wi (0), Wi (1)).
By specifying a joint model for for (Wi (0), Wi (1)), which allows for the correlation ρ between
the normalized percentiles of Wi (0) and Wi (1), we provide a stochastic generalization of the rank
preservation assumption (Efron and Feldam, 1991) similar to the one recently proposed by Dobbin
and Louis (2003). More specifically, the hypothesis of rank preservation (also called percentiles
invariance) implies that, for any group of participants the birth weight percentiles would not be
permuted if the group had been assigned to another treatment. In our model specification for the
birth weights, the percentile invariance assumption leads to ρ = 1 which also implies that all the
15
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population parameters ∆s are equal to the to causal parameters τ s.
The methodology we described has broad applicability to a variety of situation in which one
investigates a continuous post-treatment variable that potentially mediates a binary response of
interest. For example, similar issues arise in cancer trials that evaluate both tumor growth and
survival. In these studies it is likely that there are both mediated and direct effects of treatments,
and that these effects may vary across the distribution of tumor growths. In summary, we have provided an inferential framework for estimating causal effects in a randomized trial with a continuous
post-treatment variable. By comparing population with causal parameter estimates, carrying out
sensitivity analyses, and implementing principal stratification, we have characterized the amount
of evidence supporting the scientific questions of interest and their sources of uncertainty.
The estimation of treatment effects by percentile of the birth weight distribution has public
health significance. In the case study presented here, the treatment increased the birth weight of
smaller babies and had no apparent effect on larger babies. Had it increased the size of the larger
infants, both the infants and their mothers might have been at higher risk of mortality given the
absence of obstetrical care in rural communities. In such a situation, it would be necessary to
predict those mothers who are likely to have larger infants and to exclude them from intervention
programs. However, while maternal pre-pregnancy nutritional status, weight gain during pregnancy
and other factors are strong determinants of low birth weight, their ability to predict infants likely
to be born with low birth weight is still uncertain.
Currently recommendations exist for supplementing women with iron-folic acid during pregnancy
in developing countries. The Nepal study (Christian et al., 2003a) demonstrates that beyond
reducing anemia, iron can result in an improvement in birth weight primarily through moving the
lower tail of the birth weight distribution to the right. Presumably, this effect is mediated through
improving the iron status of those pregnant women who are the most iron deficient. These data
from Nepal reveal that when evaluating public health interventions it is important to be, at the very
least, cognizant of the differential beneficial effects of an intervention depending on where in the
distribution the program participants fall and that an overall effect size may: 1) under-estimate the
maximum likely benefit in the most malnourished individuals; and 2) incorrectly assume benefits
where none exist and potentially mask harm in the more well-nourished individuals.
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Table 1: Definition of population and causal parameters for estimating the effects of antenatal
iron-folic acid supplementation on birth weight as a function of birth weight percentiles. Q 1 (p)
and Q0 (p) are the quantile functions of Wi (1) and Wi0 (0), respectively. The parameters ρ and ψ
measure the correlation between Wi (0) and Wi (1) and the odds-ratio between Yi (0) and Yi (1). The
0
subscripts i and i indicate two different infants.
Percentile-specific Effects on Birth Weight
Population Parameters
| Zi0 = 0]
= E[Wi (1)] − E[Wi0 (0)] = E[Wiobs | Zi = 1] − E[Wiobs
0

Average

∆W

p-specific

∆W
p (ρ) = E[Wi (1) | F1 (Wi (1)) = p] − E[Wi0 (0) | F0 (Wi0 (0)) = p] = Q1 (p) − Q0 (p)

Average
p-specific

Causal Parameters
τ W (ρ, ψ) = E[Wi (1) − Wi (0)]
τpW (ρ, ψ) = E[Wi (1) − Wi (0) | F0 (Wi (0)) = p]

Table 2: Definition of population and causal parameters for estimating the effects of antenatal ironfolic acid supplementation on infant mortality as a function of the birth weight percentiles. The
parameters ρ and ψ measure the correlation between Wi (0) and Wi (1) and the odds-ratio between
0
Yi (0) and Yi (1). The subscripts i and i indicate two different infants.
Percentile-specific Effects on Mortality
Population Parameters
= E[Yi (1)] − E[Yi0 (0)] = E[Yiobs | Zi = 1] − E[Yiobs
| Zi0 = 0]
0

Average

∆Y

p-specific

∆Yp = E[Yi (1) | F1 (Wi (1)) = p] − E[Yi0 (0) | F0 (Wi0 (0)) = p]

Average
p-specific

Causal Parameters
τ Y (ρ, ψ) = E[Yi (1) − Yi (0)]
τpY (ρ, ψ) = E[Yi (1) − Yi (0) | F0 (Wi (0)) = p]

P-Stratification


τ1Y (ρ, ψ)



 τ Y (ρ, ψ)
2
 τ3Y (ρ, ψ)



 τ Y (ρ, ψ)
4

=
=
=
=

E[Yi (1) − Yi (0) given Wi (0) ≤ 2500 &
E[Yi (1) − Yi (0) given Wi (0) ≤ 2500 &
E[Yi (1) − Yi (0) given Wi (0) > 2500 &
E[Yi (1) − Yi (0) given Wi (0) > 2500 &

| Wi (1) − Wi (0) |≤ 50]
| Wi (1) − Wi (0) |> 50]
| Wi (1) − Wi (0) |≤ 50]
| Wi (1) − Wi (0) |> 50]
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Parameter

Prior distribution

β
µ0
µ1
σ02
σ12
γ0
γ1

flat
£
¤
N3 (1500, 2500, 3500), 5002 I
£
¤
N3 (2000, 3000, 3500), 5002 I
LN (log(4002 ), 0.8)
LN (log(4002 ), 0.8)
Dirichlet(10, 31 , 31 , 13 )
Dirichlet(10, 31 , 31 , 13 )

Table 3: Prior distributions on the unknown parameters of the mixture. I denotes a 3 × 3 identity
matrix, 5002 denotes the prior variance, LN denotes the log-normal distribution with prior mean
400 and prior standard deviation 0.8.
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Figure 1: Top: smoothed histograms of the birth weights for the treated and the control groups.
Bottom: estimated log-odds of death as smooth function of the birth weight with 95% confidence
bands and plotted in correspondence to the observed range of birth weights in the two groups.
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Figure 2: Posterior means and 95% posterior regions of the p-specific effects of treatment on
birth weight (∆W
p ) under the following modelling assumptions for (Wi (0), Wi (1)): a) Wi (0), Wi (1)
have a bivariate normal distribution with equal variances; b) Wi (0), Wi (1) have a mixture of normal
distributions with correlation ρ as defined in Section 2. The triangles denote the differences between
the empirical quantile functions for the observed data. The black dots denote the posterior means
of ∆W
p as a function of p.
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Figure 3: Panel (a): Posterior means and 95% posterior regions of the p-specific causal effects
of treatment on birth weight (τpW ) for ρ = 0.9 and for ρ = 0.5 (darker polygon). The vertical
dotted line is placed at the 0.42 percentile, corresponding to 2500 grams in the control distribution.
Panel (b): sensitivity analysis of the posterior distributions of the causal effect of treatment on
birth weight (τpW ) separately for three sub-populations of babies Wi (0) ≤ 1500; 1500 < Wi (0) ≤
2500; Wi (0) < 2500 and overall for all babies with respect to (ρ, ψ). The horizontal dotted line is
placed at the sample mean difference (∆W ).
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Figure 4: Panel a: posterior means and 95% posterior regions of the p-specific effects of treatment
on mortality (∆Yp ). Panel b: posterior means and 95% posterior regions of the p-specific causal
effects of treatment on mortality (τpY ) for ρ = 0.9 and for ρ = 0.5 (darker line). Panel c: posterior
distributions of the causal effects of treatment on mortality (τpY ) for different values of (ρ, ψ). The
posterior distributions are shown separately for five sub-populations of infants: 1) LBW infants for
whom there is causal effect of treatment on birth weight smaller than 50 grams; 2) LBW infants for
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whom there is a causal effect of treatment on birth weight larger than 50 grams; 3) not-LBW for
whom there is a causal effect of treatment on birth weight smaller than 50 grams; 4) not-LBW for
whom there is a causal effect of treatment on birth weight larger than 50 grams; and 5) all infants.

http://biostats.bepress.com/jhubiostat/paper68

Treatment

F(x)
0.0

0.0

0.2

0.2

0.4

0.4

F(x)

0.6

0.6

0.8

0.8

1.0

1.0

Control

1000

1500

2000

2500

3000

3500

4000

4500

birth weight

1000

1500

2000

2500

3000

3500

4000

4500

birth weight

Figure 5: Left and right: 95% posterior regions of F0 (Wiobs , θ j0 ) and F1 (Wiobs , θ j1 ) where F0 , F1 are
(j) (j)
the cdf of the mixture of three normal distributions, and θ 0 , θ 1 are the the j th posterior sample
of the vector of parameters of the mixture. The black lines are the corresponding empirical cdf.
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